-
Innovation Ranking
NewInnovation Ranking – AMC Networks Inc
AMC Networks Inc (AMC Networks) is an entertainment company. It produces and distributes content, distributes films, and provides subscription streaming services. The company also produces content spans multiple genres, including drama, anthology, reality, comedy, documentary, feature film and short form; and owns. Its major brands include AMC, IFC, WE tv, Shudder, ALLBLK, Acorn TV, SundanceTV, AMC Networks International, BBC AMERICA, Sundance Channel, UMC and AMC Premiere. The company also operates AMC Studios, its television production and worldwide content distribution division....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMC-303 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMC-303 in Breast Cancer Drug Details: AMC-303 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMC-303 in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMC-303 in Esophageal Cancer Drug Details: AMC-303 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Squamous Non-Small Cell Lung Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMC-303 in Squamous Non-Small Cell Lung Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMC-303 in Squamous Non-Small Cell Lung Carcinoma Drug Details:...
-
Company Insights
Innovation and Patenting activity of AMC Networks Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of AMC Networks Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMC-303 in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AMC-303 in Cervical Cancer Drug Details:AMC-303 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMC-303 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AMC-303 in Colorectal Cancer Drug Details:AMC-303 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMC-303 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AMC-303 in Breast Cancer Drug Details:AMC-303 is under development for the treatment of...